Resolid Cat 1 ml (1 doz)

Combined attenuated vaccine for cats against rhinotracheitis, calicivirosis and panleukopenia.

Target species

Cats

Indications

RESOLID CAT is used in cats for protection against viral rhinotracheitis caused by feline herpesvirus 1, calicivirosis caused by feline calicivirus and panleukopenia caused by feline panleukopenia virus. After the booster, immunity develops through an immune response after 4 weeks for feline calicivirus and feline herpesvirus 1, and after 3 weeks for feline panleukopenia. The duration of immunity is 1 year after vaccination.

Composition

Freeze-dried powder for suspension for injection

Solvent for parenteral use

Active substance · Amount · Function

Attenuated feline calicivirus F9 strain · ≥10⁴·⁶ TCID₅₀/dose* · Immunising antigen

Attenuated feline herpesvirus type 1 FVRm strain · ≥10⁵·² TCID₅₀/dose*

Attenuated feline panleukopenia Philips-Roxane strain · ≥10⁴·⁰ FAID₅₀/dose**

Excipients

Lactalbumin hydrolysate · 0.25 mg/dose · Stabiliser

Sucrose · 0.50 mg/dose

Components · Amount · Function

Sodium chloride · 8.5 mg/ml · Diluent

Disodium hydrogen phosphate heptahydrate · 0.18 mg/ml

Sodium dihydrogen phosphate dihydrate · 0.06 mg/ml

Water for injections · 1 ml q.s.

*Tissue Culture Infective Dose

**Fluorescent Antibody Infective Dose

Dosage and administration

Add the solvent to the freeze-dried pellet. Reconstitute the vaccine slowly to obtain a homogeneous suspension with limited foaming. After reconstitution, a pink, clear suspension for injection is obtained. Draw it into a syringe and give 1 dose (1 ml) subcutaneously to kittens from 8 weeks of age and to adult cats. For a protective level of immunity, vaccinate twice, 4 weeks apart. Vaccination should be repeated every year.